Healthcare -
Biotechnology - NASDAQ - US
$ 5.17
2.64 %
$ 461 M
Market Cap
-1.63
P/E
AMLX - CASH FROM OPERATIONS
Cash from Operations AMLX - Amylyx Pharmaceuticals, Inc.
-168 M
LAST VALUE
3.46%
2 YEAR CAGR
-73.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR